[Brugada's syndrome: experience in Cuba in 2001]

Francisco Dorticós Balea1, Margarita Dorantes Sánchez, Jorge Luis Arbaiza Simón

  • 1Servicio de Arritmias y Estimulación Cardíaca, Instituto de Cardiología y Cirugía Cardiovascular Ciudad de La Habana, Cuba. marccard@infomed.sld.cu

Insights

Brugada syndrome, a genetic heart condition, was studied in 14 Cuban patients. Early diagnosis and implantable cardioverter-defibrillators are key for managing life-threatening arrhythmias and preventing sudden cardiac death.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Genetics

Context:

  • Brugada syndrome is a primary electrical disorder causing sudden cardiac death in individuals with structurally normal hearts.
  • It presents with characteristic ECG abnormalities like ST segment elevation and pseudo right bundle branch block.
  • The syndrome predisposes individuals to life-threatening ventricular arrhythmias.

Purpose:

  • To characterize patients diagnosed with Brugada syndrome in Cuba between 1995 and 2001.
  • To evaluate diagnostic tools and treatment strategies for Brugada syndrome in this cohort.

Summary:

  • Fourteen patients (13 male, 1 female, mean age 42.8) were studied, with 7 symptomatic and 7 asymptomatic.
  • Pharmacological testing with sodium channel blockers proved highly effective (100% positive).
  • Programmed ventricular stimulation induced arrhythmias in 5 patients (3 symptomatic, 2 asymptomatic).
  • Implantable cardioverter-defibrillators were used for all symptomatic patients and inducible asymptomatic cases.
  • A single recurrence of ventricular arrhythmia was noted, with rare use of antiarrhythmic drugs.

Impact:

  • Highlights the diagnostic utility of clinical history, ECG, and pharmacological challenge in Brugada syndrome.
  • Emphasizes the implantable cardioverter-defibrillator as the primary treatment for preventing sudden cardiac death.
  • Suggests that even masked or transient ECG findings warrant consideration for Brugada syndrome diagnosis.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...